Cipla promoters Shirin Hamied, Rumana Hamied, Samina Hamied and Okasa Pharma have sold 2.53% shares worth around ₹2,600 crore, the company announced in an exchange filing on Wednesday. Cipla said the purpose of the sale of stake was to create "liquidity for specific needs including philanthropy". The company added the entire promoter group now owns 31.67% after the sale.